Wolff Wiese Magana’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-660
Closed -$36K – 855
2022
Q3
$36K Sell
660
-57
-8% -$2.93K 0.03% 286
2022
Q2
$29K Hold
717
– – 0.02% 335
2022
Q1
$47K Hold
717
– – 0.03% 282
2021
Q4
$72K Hold
717
– – 0.05% 234
2021
Q3
$90K Hold
717
– – 0.06% 207
2021
Q2
$89K Buy
717
+109
+18% +$14.7K 0.06% 209
2021
Q1
$93K Sell
608
-36
-6% -$5.44K 0.07% 194
2020
Q4
$83K Buy
+644
New +$74.1K 0.07% 196

Other funds holding GH

Wolff Wiese Magana's GH Position: Q4 2022 in Review

Wolff Wiese Magana sold out of Guardant Health (GH) in Q4 2022, closing a stake of 660 shares — an estimated $36K sold.

Wolff Wiese Magana first reported a position in GH in Q4 2020 and held it in 8 quarters. The position peaked at $93K in Q1 2021. 290 funds tracked by Wall St. Rank hold GH as of Q4 2022.

  • Wolff Wiese Magana reported no remaining Guardant Health position as of Q4 2022 after selling out during the quarter.
  • Wolff Wiese Magana sold 660 Guardant Health shares in Q4 2022, an estimated $36K.
  • Wolff Wiese Magana first reported a position in Guardant Health in Q4 2020 and held it in 8 quarters.
  • Wolff Wiese Magana's Guardant Health position peaked at $93K in Q1 2021.
  • 290 funds tracked by Wall St. Rank held Guardant Health as of Q4 2022.

Based on Wolff Wiese Magana's 13F filing for Q4 2022, filed 9 Feb 2023.